Search

everythinglearnresearchcommunity

for

Search:↓

TIP39 and PTH2R help control calcium levels and skin cell development.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Finasteride blocks deoxycorticosterone's anticonvulsant effects in infant rats, but indomethacin doesn't.

Polydopamine is promising for personalized medicine and biomedical technology due to its strong adhesion and biocompatibility.

TRPA1 and TRPV1 channels don't affect mechanotransduction in rat sinus hair follicles.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Putting thymidine dinucleotide on newborn mice's skin can delay and reduce skin cancer.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

PRAME is often present in Paget disease and could help in diagnosis, but more research is needed.

Two new compounds were found to effectively reduce hair growth in mice.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

Promising cancer treatments were found, but the manufacturer closed.

A reliable method was developed to measure Tamsulosin and Finasteride in tablets accurately.

Retinol acetate can reduce the harmful effects of the drug benoxaprofen on white blood cells.

Beta-blockers and anti-anginal medications have various side effects and interactions that require careful monitoring and individualized treatment.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

SIP is a better method for measuring hair growth accurately.

Tofacitinib significantly improved skin and hair conditions without side effects.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

The diphosphonate was the most effective at preventing calcification in rats.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Method can accurately measure five BPH drugs at once.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

The developed nasal gel improves cilostazol delivery to the brain, enhancing its effectiveness and reducing side effects.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.